ARQT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $20,137,464.89

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$17.28

▼ -0.23 (-1.31%)

As of 12/5/2022 04:09 PM ET

Days: 30 | 90 | 365

The Lithium "Lie"

From Investing Trends | Ad

Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China.

Find Out How Investors Can Benefit From the Energy

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/21/2022	Masaru Matsuda	Insider	Sell	1,720	$18.19	$31,286.80	19,535
11/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$18.00	$18,000.00	379,907
10/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$19.51	$19,510.00	380,907
10/4/2022	Howard G. Welgus	Director	Sell	6,000	$20.29	$121,740.00	168,208
9/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.51	$21,510.00	381,907
8/15/2022	Howard G. Welgus	Director	Sell	6,000	$24.80	$148,800.00	174,208
7/18/2022	Howard G. Welgus	Director	Sell	6,000	$24.40	$146,400.00	180,208
7/8/2022	David W Osborne	Insider	Sell	2,197	$25.41	$55,825.77	256,649
7/8/2022	Todd Franklin Watanabe	CEO	Sell	13,500	$25.37	$342,495.00	651,871
7/6/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$22.07	$22,070.00	658,284
6/24/2022	Orbimed Advisors Llc	Major Shareholder	Sell	341,971	$21.31	$7,287,402.01	415,142
6/2/2022	Masaru Matsuda	SVP	Sell	1,795	$19.73	$35,415.35	16,380
6/1/2022	Howard G. Welgus	Director	Sell	2,500	$20.62	$51,550.00	181,896
5/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.76	$21,760.00	658,667
5/2/2022	Howard G. Welgus	Director	Sell	2,500	$20.44	$51,100.00	181,896
4/21/2022	David W Osborne	Insider	Sell	2,197	$20.42	$44,862.74	257,229
4/8/2022	Orbimed Advisors Llc	Major Shareholder	Sell	200,000	$20.71	$4,142,000.00
4/6/2022	Orbimed Advisors Llc	Major Shareholder	Sell	333,204	$20.69	$6,893,990.76
4/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.43	$21,430.00	659,667
4/1/2022	Howard G. Welgus	Director	Sell	7,500	$20.02	$150,150.00
3/9/2022	Todd Franklin Watanabe	CEO	Sell	300	$17.00	$5,100.00
3/7/2022	Patrick Burnett	Insider	Sell	30	$16.44	$493.20
3/7/2022	Scott L. Burrows	CFO	Sell	10	$16.44	$164.40
3/7/2022	Todd Franklin Watanabe	CEO	Sell	770	$17.05	$13,128.50
3/4/2022	Patricia A. Turney	SVP	Sell	993	$16.86	$16,741.98
3/4/2022	Patrick Burnett	Insider	Sell	981	$16.86	$16,539.66
3/4/2022	Scott L. Burrows	CFO	Sell	293	$16.86	$4,939.98
3/4/2022	Todd Franklin Watanabe	CEO	Sell	2,489	$16.86	$41,964.54
2/9/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
1/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.59	$21,590.00
1/3/2022	Howard G. Welgus	Director	Sell	2,500	$21.21	$53,025.00
12/27/2021	Scott L. Burrows	CFO	Sell	12,560	$20.07	$252,079.20
12/23/2021	Howard G. Welgus	Director	Sell	2,500	$20.16	$50,400.00
12/8/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
11/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.50	$21,500.00
11/1/2021	Howard G. Welgus	Director	Sell	2,500	$21.81	$54,525.00
10/5/2021	Todd Franklin Watanabe	CEO	Sell	2,500	$24.92	$62,300.00
9/7/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.14	$21,140.00
8/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$20.81	$20,810.00
7/6/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.58	$46,515.00
7/1/2021	Howard G. Welgus	Director	Sell	2,200	$26.13	$57,486.00
6/24/2021	Bhaskar Chaudhuri	Director	Sell	729	$27.50	$20,047.50	848,146
6/21/2021	Bhaskar Chaudhuri	Director	Sell	2,516	$27.50	$69,190.00	848,875
6/7/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.35	$46,112.50
5/7/2021	Todd Franklin Watanabe	CEO	Sell	750	$35.00	$26,250.00
5/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$34.00	$59,500.00
4/20/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$28.06	$280,600.00	862,671
4/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$29.93	$52,377.50
4/1/2021	Howard G. Welgus	Director	Sell	2,200	$29.49	$64,878.00
3/22/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$31.10	$311,000.00	876,383
3/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$30.55	$53,462.50
2/10/2021	John W. Smither	CFO	Sell	750	$35.64	$26,730.00
2/1/2021	Bhaskar Chaudhuri	Director	Sell	9,949	$33.25	$330,804.25	901,340
2/1/2021	John W. Smither	CFO	Sell	1,250	$35.00	$43,750.00
1/29/2021	Bhaskar Chaudhuri	Director	Sell	51	$27.50	$1,402.50	901,340
1/19/2021	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
12/1/2020	Howard G. Welgus	Director	Sell	2,200	$25.98	$57,156.00	180,234
10/1/2020	Howard G. Welgus	Director	Sell	2,200	$27.65	$60,830.00	179,210
9/29/2020	David W. Osborne	Insider	Sell	15,000	$30.00	$450,000.00
9/29/2020	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
9/29/2020	Todd Franklin Watanabe	CEO	Sell	3,000	$30.00	$90,000.00	569,928
9/1/2020	Howard G. Welgus	Director	Sell	2,200	$24.38	$53,636.00	178,378
8/3/2020	Howard G. Welgus	Director	Sell	2,800	$25.63	$71,764.00	162,725
2/4/2020	Life Sciences Viii L Frazier	Major Shareholder	Buy	500,000	$24.10	$12,050,000.00
2/3/2020	Jonathan Silverstein	Director	Buy	558,888	$25.64	$14,329,888.32

The "NEW" Oil and Gas Crisis: Lack Of Lithium

From Investing Trends | Ad

We are in a global lithium crisis that's going to get far worse. Just like OPEC and Russia control the price and supply of oil and gas, China has the U.S. in a chokehold when it comes to lithium.

Click here to see how the prices may explode

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/21/2022	California State Teachers Retirement System	51,625	$0.99M	0.0%	+26.9%	0.085%
11/16/2022	Fred Alger Management LLC	26,324	$0.50M	0.0%	N/A	0.043%
11/16/2022	Jane Street Group LLC	19,081	$0.37M	0.0%	-72.8%	0.031%
11/15/2022	Neuberger Berman Group LLC	131,979	$2.52M	0.0%	-3.5%	0.217%
11/15/2022	State Street Corp	2,655,235	$50.74M	0.0%	+90.1%	4.358%
11/15/2022	Jacobs Levy Equity Management Inc.	232,213	$4.44M	0.0%	N/A	0.381%
11/15/2022	Algert Global LLC	22,126	$0.42M	0.0%	N/A	0.036%
11/15/2022	Thrivent Financial for Lutherans	33,914	$0.65M	0.0%	N/A	0.056%
11/15/2022	Two Sigma Advisers LP	71,200	$1.36M	0.0%	N/A	0.117%
11/15/2022	Two Sigma Investments LP	62,808	$1.20M	0.0%	N/A	0.103%
11/15/2022	UBS Asset Management Americas Inc.	19,100	$0.37M	0.0%	-36.3%	0.031%
11/15/2022	Vanguard Group Inc.	2,252,939	$43.05M	0.0%	+25.3%	3.698%
11/15/2022	Price T Rowe Associates Inc. MD	179,294	$3.43M	0.0%	-60.4%	0.294%
11/15/2022	Logos Global Management LP	1,525,000	$29.14M	3.6%	+52.5%	2.503%
11/15/2022	Marshall Wace LLP	167,816	$3.21M	0.0%	N/A	0.275%
11/15/2022	Martingale Asset Management L P	27,108	$0.52M	0.0%	N/A	0.044%
11/15/2022	EcoR1 Capital LLC	415,322	$7.94M	0.2%	-53.6%	0.682%
11/15/2022	Ensign Peak Advisors Inc	489,345	$9.35M	0.0%	+28.8%	0.803%
11/15/2022	Bank of New York Mellon Corp	124,609	$2.38M	0.0%	+30.6%	0.205%
11/15/2022	Bioimpact Capital LLC	257,185	$4.92M	1.2%	-0.5%	0.422%
11/15/2022	BlackRock Inc.	5,081,744	$97.11M	0.0%	+11.0%	8.340%
11/15/2022	Citadel Advisors LLC	80,515	$1.54M	0.0%	-61.7%	0.132%
11/14/2022	Tudor Investment Corp Et Al	18,349	$0.35M	0.0%	N/A	0.030%
11/14/2022	Cormorant Asset Management LP	1,000,000	$19.11M	1.3%	N/A	1.641%
11/14/2022	Point72 Asset Management L.P.	3,785,277	$72.34M	0.3%	+90.5%	6.213%
11/14/2022	PDT Partners LLC	12,673	$0.24M	0.0%	N/A	0.021%
11/14/2022	Renaissance Technologies LLC	65,000	$1.24M	0.0%	+501.9%	0.107%
11/14/2022	Nuveen Asset Management LLC	532,875	$10.18M	0.0%	+47.6%	0.875%
11/14/2022	AXA S.A.	337,595	$6.45M	0.0%	+51.0%	0.554%
11/14/2022	Rubric Capital Management LP	472,047	$9.02M	0.5%	+108.6%	0.775%
11/14/2022	MetLife Investment Management LLC	21,747	$0.42M	0.0%	+30.1%	0.036%
11/14/2022	Hsbc Holdings PLC	130,724	$2.50M	0.0%	+17.0%	0.215%
11/14/2022	E Fund Management Co. Ltd.	11,947	$0.23M	0.0%	N/A	0.020%
11/14/2022	Pictet Asset Management SA	1,602,786	$30.63M	0.0%	+73.7%	2.631%
11/14/2022	Hennion & Walsh Asset Management Inc.	90,264	$1.73M	0.1%	-2.6%	0.148%
11/10/2022	Credit Suisse AG	34,853	$0.67M	0.0%	+96.5%	0.068%
11/10/2022	ExodusPoint Capital Management LP	47,055	$0.90M	0.0%	N/A	0.091%
11/10/2022	Dimensional Fund Advisors LP	313,943	$6M	0.0%	+0.4%	0.609%
11/10/2022	Tower Research Capital LLC TRC	2,830	$54K	0.0%	-76.2%	0.005%
11/10/2022	UBS Group AG	23,572	$0.45M	0.0%	+41.0%	0.046%
11/9/2022	Amalgamated Bank	6,612	$0.13M	0.0%	+19.5%	0.013%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	5,892	$0.11M	0.0%	+332.6%	0.011%
11/8/2022	Sofinnova Investments Inc.	274,330	$5.24M	0.3%	N/A	0.532%
11/7/2022	Arizona State Retirement System	11,208	$0.21M	0.0%	N/A	0.022%
11/4/2022	Vontobel Holding Ltd.	10,516	$0.20M	0.0%	N/A	0.020%
11/4/2022	Russell Investments Group Ltd.	13,198	$0.25M	0.0%	N/A	0.026%
11/3/2022	Teacher Retirement System of Texas	13,407	$0.26M	0.0%	N/A	0.026%
11/3/2022	Barclays PLC	140,837	$2.69M	0.0%	+304.3%	0.273%
11/2/2022	DekaBank Deutsche Girozentrale	30,000	$0.57M	0.0%	+114.3%	0.058%
11/2/2022	Victory Capital Management Inc.	25,000	$0.48M	0.0%	N/A	0.048%
11/1/2022	Jennison Associates LLC	1,389,616	$26.56M	0.0%	+219.4%	2.695%
10/31/2022	SG Americas Securities LLC	11,296	$0.22M	0.0%	-17.2%	0.022%
10/26/2022	Allspring Global Investments Holdings LLC	728,364	$13.92M	0.0%	+15.7%	1.413%
10/26/2022	Fishman Jay A Ltd. MI	46,800	$0.89M	0.1%	+122.9%	0.091%
9/2/2022	Amundi	4,774	$0.11M	0.0%	N/A	0.009%
8/22/2022	Legal & General Group Plc	11,804	$0.25M	0.0%	+35.2%	0.023%
8/18/2022	Goldman Sachs Group Inc.	96,178	$2.05M	0.0%	+53.7%	0.187%
8/16/2022	Price T Rowe Associates Inc. MD	453,057	$9.66M	0.0%	+1.0%	0.879%
8/16/2022	Prudential Financial Inc.	66,495	$1.42M	0.0%	N/A	0.129%
8/16/2022	Pura Vida Investments LLC	100,000	$2.13M	0.1%	-47.2%	0.194%
8/15/2022	State Street Corp	1,396,425	$29.76M	0.0%	+17.4%	2.708%
8/15/2022	Point72 Hong Kong Ltd	1,197	$26K	0.0%	+102.9%	0.002%
8/15/2022	Cubist Systematic Strategies LLC	49,047	$1.05M	0.0%	+646.6%	0.095%
8/15/2022	Point72 Asset Management L.P.	1,987,431	$42.35M	0.2%	+17.1%	3.854%
8/15/2022	Bain Capital Life Sciences Investors LLC	3,000,000	$63.93M	7.5%	-24.6%	5.818%
8/15/2022	Sei Investments Co.	143,938	$3.07M	0.0%	N/A	0.279%
8/13/2022	Renaissance Technologies LLC	10,800	$0.23M	0.0%	N/A	0.021%
8/13/2022	American International Group Inc.	16,394	$0.35M	0.0%	+19.4%	0.032%
8/12/2022	Northern Trust Corp	315,058	$6.71M	0.0%	+21.7%	0.611%
8/12/2022	Virtus ETF Advisers LLC	5,232	$0.11M	0.0%	-49.5%	0.010%
8/12/2022	Ensign Peak Advisors Inc	379,895	$8.10M	0.0%	-23.3%	0.737%
8/12/2022	Credit Suisse AG	17,741	$0.38M	0.0%	+2.9%	0.034%
8/12/2022	Rafferty Asset Management LLC	42,377	$0.90M	0.0%	-26.0%	0.082%
8/12/2022	FMR LLC	7,712,680	$164.36M	0.0%	+2.1%	14.959%
8/12/2022	Franklin Resources Inc.	793,896	$16.92M	0.0%	+20.3%	1.540%
8/12/2022	Rhumbline Advisers	41,345	$0.88M	0.0%	+17.0%	0.080%
8/11/2022	UBS Group AG	16,719	$0.36M	0.0%	-69.2%	0.032%
8/11/2022	Alps Advisors Inc.	30,499	$0.65M	0.0%	-41.1%	0.059%
8/11/2022	JPMorgan Chase & Co.	33,112	$0.71M	0.0%	+22.5%	0.064%
8/10/2022	1492 Capital Management LLC	177,959	$3.79M	2.5%	+136.7%	0.345%
8/10/2022	Principal Financial Group Inc.	11,087	$0.24M	0.0%	N/A	0.022%
8/9/2022	Swiss National Bank	71,200	$1.52M	0.0%	+19.7%	0.138%
8/9/2022	Pictet Asset Management SA	922,894	$19.67M	0.0%	N/A	1.790%
8/5/2022	State Board of Administration of Florida Retirement System	13,787	$0.29M	0.0%	N/A	0.027%
8/2/2022	Jennison Associates LLC	435,019	$9.27M	0.0%	N/A	0.846%
7/29/2022	Tekla Capital Management LLC	148,874	$3.17M	0.1%	+13.1%	0.290%
7/29/2022	SG Americas Securities LLC	13,646	$0.29M	0.0%	N/A	0.027%
7/25/2022	Allspring Global Investments Holdings LLC	629,754	$13.42M	0.0%	+3.3%	1.225%
7/20/2022	Denali Advisors LLC	2,600	$55K	0.0%	-29.7%	0.005%
7/19/2022	Hennion & Walsh Asset Management Inc.	92,653	$1.97M	0.1%	+6.0%	0.180%
7/18/2022	Denali Advisors LLC	2,600	$55K	0.0%	-29.7%	0.005%
6/30/2022	Amalgamated Bank	3,459	$67K	0.0%	N/A	0.007%
6/7/2022	Bank of America Corp DE	10,000	$0.19M	0.0%	-17.4%	0.019%
5/27/2022	Walleye Capital LLC	75,553	$1.46M	0.0%	-9.4%	0.147%
5/23/2022	Neuberger Berman Group LLC	129,276	$2.49M	0.0%	+5.9%	0.251%
5/17/2022	Walleye Capital LLC	75,553	$1.46M	0.0%	-9.4%	0.147%
5/17/2022	Jane Street Group LLC	14,398	$0.28M	0.0%	N/A	0.028%
5/17/2022	Quantbot Technologies LP	2,300	$44K	0.0%	N/A	0.004%
5/17/2022	Royal Bank of Canada	1,900	$37K	0.0%	-62.8%	0.004%
5/17/2022	Ensign Peak Advisors Inc	495,450	$9.54M	0.0%	+18.1%	0.964%

Data available starting January 2016

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $17.28

$17.09

$17.39

50 Day Range

MA: $18.29

$16.62

$20.40

52 Week Range

Now: $17.28

$13.59

$27.40

Volume

12,827 shs

Average Volume

499,541 shs

Market Capitalization

$1.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Bhaskar Chaudhuri (Director)
Todd Franklin Watanabe (CEO)
Orbimed Advisors Llc (Major Shareholder)
Todd Franklin Watanabe (Insider)
David W Osborne (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
Masaru Matsuda (SVP)
Howard G Welgus (Director)
John W Smither (CFO)
Patricia A Turney (SVP)
Patrick Burnett (Insider)
Scott L Burrows (CFO)
Learn More about top insider investors at Arcutis Biotherapeutics.
Who are the major institutional investors of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top institutional shareholders include:
BlackRock Inc. — 8.34%
Point72 Asset Management L.P. — 6.21%
State Street Corp — 4.36%
Vanguard Group Inc. — 3.70%
Pictet Asset Management SA — 2.63%
Logos Global Management LP — 2.50%
Learn More about top institutional investors of Arcutis Biotherapeutics stock.
Which institutional investors are selling Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was sold by these institutional investors:
EcoR1 Capital LLC
Price T Rowe Associates Inc. MD
Citadel Advisors LLC
Jane Street Group LLC
SG3 Management LLC
UBS Asset Management Americas Inc.
Tower Research Capital LLC TRC
Neuberger Berman Group LLC
In the last year, company insiders that have sold Arcutis Biotherapeutics company stock include:
Bhaskar Chaudhuri (Director)
Todd Franklin Watanabe (CEO)
Orbimed Advisors Llc (Major Shareholder)
Todd Franklin Watanabe (Insider)
David W Osborne (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
Masaru Matsuda (SVP)
Howard G Welgus (Director)
John W Smither (CFO)
Learn More investors selling Arcutis Biotherapeutics stock.
Which institutional investors are buying Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was purchased by institutional investors including:
Point72 Asset Management L.P.
State Street Corp
Cormorant Asset Management LP
Jennison Associates LLC
Pictet Asset Management SA
Logos Global Management LP
BlackRock Inc.
Vanguard Group Inc.